SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi &.